Research Paper Volume 12, Issue 13 pp 12930—12942

Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis

class="figure-viewer-img"

Figure 2. Meta-analysis of the composite outcomes of all-cause death, myocardial infarction, stent thrombosis and stroke. Horizontal lines represent the 95% CI of the effect size; solid square indicate the mean effect size in single studies; hollow diamond shapes depict the summary effect size (diamond center) and the relative 95% CI (lateral edges); the black vertical lines represent the reference “1” line.